GB0018686D0 - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- GB0018686D0 GB0018686D0 GB0018686A GB0018686A GB0018686D0 GB 0018686 D0 GB0018686 D0 GB 0018686D0 GB 0018686 A GB0018686 A GB 0018686A GB 0018686 A GB0018686 A GB 0018686A GB 0018686 D0 GB0018686 D0 GB 0018686D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0018686A GB0018686D0 (en) | 2000-07-28 | 2000-07-28 | Pharmaceutical formulation |
AU22068/01A AU2206801A (en) | 1999-12-24 | 2000-12-21 | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
AT00985666T ATE291898T1 (en) | 1999-12-24 | 2000-12-21 | PHARMACEUTICAL AEROSOL FORMULATION CONTAINING SALMETEROL AND FLUTICASONE |
ES00985666T ES2238334T3 (en) | 1999-12-24 | 2000-12-21 | PHARMACEUTICAL FORMULATION IN SALMETEROL AEROSOL AND FLUTICASONA PROPIONATE. |
DE60019167T DE60019167T2 (en) | 1999-12-24 | 2000-12-21 | PHARMACEUTICAL AEROSOL FORMULATION CONTAINING SALMETEROL AND FLUTICASONE |
JP2001548088A JP2003518484A (en) | 1999-12-24 | 2000-12-21 | Pharmaceutical aerosol formulations of salmeterol and fluticasone propionate |
EP00985666A EP1248597B1 (en) | 1999-12-24 | 2000-12-21 | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
PCT/GB2000/004939 WO2001047493A1 (en) | 1999-12-24 | 2000-12-21 | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
US10/168,672 US20030032632A1 (en) | 1999-12-24 | 2000-12-21 | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0018686A GB0018686D0 (en) | 2000-07-28 | 2000-07-28 | Pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0018686D0 true GB0018686D0 (en) | 2000-09-20 |
Family
ID=9896635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0018686A Ceased GB0018686D0 (en) | 1999-12-24 | 2000-07-28 | Pharmaceutical formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0018686D0 (en) |
-
2000
- 2000-07-28 GB GB0018686A patent/GB0018686D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL156716A0 (en) | Pharmaceutical formulation | |
GB0118689D0 (en) | Pharmaceutical formulation | |
PL366432A1 (en) | Pharmaceutical formulation | |
PL366067A1 (en) | Oxayolidinone tablet formulation | |
GB9909154D0 (en) | Pharmaceutical formulation | |
GB0014851D0 (en) | Novel pharmaceutical formulation | |
GB9926251D0 (en) | Pharmaceutical formulation | |
GB0014947D0 (en) | Novel pharmaceutical formulation | |
GB0014892D0 (en) | Novel pharmaceutical formulation | |
GB0014883D0 (en) | Novel pharmaceutical formulation | |
GB0021487D0 (en) | Pharmaceutical | |
EP1414417A4 (en) | Pharmaceutical formulation | |
GB0104749D0 (en) | Pharmaceutical formulation | |
GB0014869D0 (en) | Novel pharmaceutical formulation | |
GB0014849D0 (en) | Pharmaceutical aerosol formulation | |
GB0019084D0 (en) | Pharmaceutical formulation | |
GB0018686D0 (en) | Pharmaceutical formulation | |
GB0018654D0 (en) | Pharmaceutical formulation | |
GB0014451D0 (en) | Pharmaceutical formulation | |
GB0014424D0 (en) | Pharmaceutical formulation | |
GB0019840D0 (en) | Novel pharmaceutical formulation | |
GB0002691D0 (en) | Pharmaceutical composition | |
GB0124712D0 (en) | Pharmaceutical formulation | |
GB9910636D0 (en) | Pharmaceutical formulation | |
GB9910633D0 (en) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |